Companies
S&P 500Health Care· USA
VRTX
Status-Quo-PlayerVertex Pharmaceuticals
$440.05
+0.86%
Open $434.17·Prev $436.29
as of 13 Apr
STATUS-QUO-PLAYER
Power Core
Power Core in one sentence: Vertex's moat is the compounding molecular complexity of the CFTR protein itself, which has defeated every external challenger's drug design efforts for over a decade, transforming a patent-protected franchise into a biology-protected monopoly.
Published1 Apr 2026
UniverseS&P 500
SectorHealth Care
↑
Direction of Movement
Upward, Compounding Through Franchise Depth and Pipeline Breadth
ROC 200
-2.7%